Kara L. Lynch

6.1k total citations · 1 hit paper
119 papers, 2.9k citations indexed

About

Kara L. Lynch is a scholar working on Toxicology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Kara L. Lynch has authored 119 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Toxicology, 30 papers in Molecular Biology and 19 papers in Infectious Diseases. Recurrent topics in Kara L. Lynch's work include Forensic Toxicology and Drug Analysis (36 papers), SARS-CoV-2 and COVID-19 Research (16 papers) and Opioid Use Disorder Treatment (14 papers). Kara L. Lynch is often cited by papers focused on Forensic Toxicology and Drug Analysis (36 papers), SARS-CoV-2 and COVID-19 Research (16 papers) and Opioid Use Disorder Treatment (14 papers). Kara L. Lynch collaborates with scholars based in United States, China and Netherlands. Kara L. Lynch's co-authors include Alan H.B. Wu, Patil Armenian, Kathy T. Vo, Jill Barr‐Walker, Cassandra Yun, Thomas F.J. Martin, Roy Gerona, Jennifer M. Colby, Katie Thoren and Ruben Yiqi Luo and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Clinical Infectious Diseases.

In The Last Decade

Kara L. Lynch

115 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review

2017 468 citations Patil Armenian, Kara L. Lynch et al. profile →

Peers

Countries citing papers authored by Kara L. Lynch

Since Specialization

Citations

This map shows the geographic impact of Kara L. Lynch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kara L. Lynch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kara L. Lynch more than expected).

Fields of papers citing papers by Kara L. Lynch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kara L. Lynch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kara L. Lynch. The network helps show where Kara L. Lynch may publish in the future.

Co-authorship network of co-authors of Kara L. Lynch

This figure shows the co-authorship network connecting the top 25 collaborators of Kara L. Lynch. A scholar is included among the top collaborators of Kara L. Lynch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kara L. Lynch. Kara L. Lynch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Quantitative LC-MS/MS Method for Xylazine and Metabolites in Urine 2024 ·American Journal of Clinical Pathology ·(unknown), Kara L. Lynch, (unknown)	1
2	Distinct patterns of cigarette smoking intensity and other substance use among women who experience housing instability 2024 ·Addictive Behaviors ·Maya Vijayaraghavan, Holly Elser, Kevin Delucchi, Janice Y. Tsoh, Kara L. Lynch, Sheri D. Weiser, Elise D. Riley	1
3	Serum microRNA‑122 for assessment of acute liver injury in patients with extensive skeletal muscle damage 2024 ·Laboratory Medicine ·Yu Zhang, (unknown), Kara L. Lynch, Javier C. Waksman, Alan H.B. Wu	0
4	Testing the test strips: laboratory performance of fentanyl test strips 2024 ·Harm Reduction Journal ·(unknown), (unknown), Daniel Ciccarone, Kara L. Lynch	19
5	Multiple substance use and blood pressure in women experiencing homelessness 2023 ·Addictive Behaviors Reports ·Leslie W. Suen, Eric Vittinghoff, Alan H.B. Wu, (unknown), Phillip O. Coffin, Priscilla Y. Hsue, Kara L. Lynch, Dhruv S. Kazi, Elise D. Riley	2
6	Development of a Machine Learning Algorithm for Drug Screening Analysis on High-Resolution UPLC-MSE/QTOF Mass Spectrometry 2023 ·The Journal of Applied Laboratory Medicine ·Ying Hao, Kara L. Lynch, Ping Yu Fan, (unknown), María C. Cid, Zhen Zhao, He S. Yang	5
7	Predictive Value of ABCC2 and UGT1A1 Polymorphisms on Irinotecan-Related Toxicities in Patients with Cancer 2023 ·Genetic Testing and Molecular Biomarkers ·(unknown), Andrew J. O. Smith, (unknown), (unknown), Hassan Ghazal, (unknown), Bouchra Meddah, Kara L. Lynch, Yahia Cherrah, Alan H.B. Wu	1
8	Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19 2021 ·Cell Reports ·Jason Neidleman, Xiaoyu Luo, Ashley F. George, Matthew McGregor, Junkai Yang, Cassandra Yun, Victoria Murray, Gurjot Gill, Warner C. Greene, Joshua Vasquez, Sulggi A. Lee, Eliver Ghosn, Kara L. Lynch, Nadia R. Roan	58
9	Refractory vasodilatory shock secondary to metformin overdose supported with VA ECMO 2021 ·Toxicology Reports ·Crystal Ives Tallman, Yu Zhang, Nicholas Black, Kara L. Lynch, Mohamed Fayed, Patil Armenian	11
10	Magnitude and Kinetics of Anti–Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Responses and Their Relationship to Disease Severity 2020 ·Clinical Infectious Diseases ·Kara L. Lynch, Jeffrey D. Whitman, (unknown), (unknown), (unknown), Brian R. Shy, Gregory M. Goldgof, Andrew G. Levine, Sagar P. Bapat, Susan L. Stramer, Jonathan H. Esensten, Allen W. Hightower, Caryn Bern, Alan H.B. Wu	126
11	Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Avidity Maturation and Association with Disease Severity 2020 ·Clinical Infectious Diseases ·Ruben Yiqi Luo, Indrani Chakraborty, Cassandra Yun, Alan H.B. Wu, Kara L. Lynch	40
12	Addressing overdose risk among unstably housed women in San Francisco, California: an examination of potential fentanyl contamination of multiple substances 2020 ·Harm Reduction Journal ·Meredith C. Meacham, Kara L. Lynch, Phillip O. Coffin, (unknown), Eliza Wheeler, Elise D. Riley	12
13	Improvement of drug identification in urine by LC-QqTOF using a probability-based library search algorithm 2017 ·PubMed ·Jennifer M. Colby, (unknown), (unknown), (unknown), Kara L. Lynch	6
14	Clenbuterol causing non–ST-segment elevation myocardial infarction in a teenage female desiring to lose weight: case and brief literature review 2016 ·The American Journal of Emergency Medicine ·(unknown), Hsien‐Yi Chen, He S. Yang, Kara L. Lynch, Kent R. Olson	11
15	Promethazine use among chronic pain patients 2015 ·Drug and Alcohol Dependence ·Kara L. Lynch, (unknown), Diana Coffa, Scott P. Novak, Alex H. Kral	29
16	CLSI C62-A: A New Standard for Clinical Mass Spectrometry 2015 ·Clinical Chemistry ·Kara L. Lynch	109
17	Comparison of Information-Dependent Acquisition on a Tandem Quadrupole TOF vs a Triple Quadrupole Linear Ion Trap Mass Spectrometer for Broad-Spectrum Drug Screening 2015 ·Clinical Chemistry ·Katie Thoren, Jennifer M. Colby, Sarah Shugarts, Alan H.B. Wu, Kara L. Lynch	67
18	Estimation of tamoxifen metabolite concentrations in the blood of breast cancer patients through CYP2D6 genotype activity score 2012 ·Breast Cancer Research and Treatment ·Alan H.B. Wu, Wendy Lorizio, Simone Tchu, Kara L. Lynch, Roy Gerona, (unknown), Weiming Ruan, Kathryn J. Ruddy, Stephen DeSantis, Harold J. Burstein, Elad Ziv	11
19	Vitamin D status of county hospital patients assessed by the DiaSorin LIAISON® 25-hydroxyvitamin D assay 2010 ·Clinica Chimica Acta ·Deborah French, (unknown), (unknown), (unknown), Kara L. Lynch, Alan H.B. Wu	14
20	Synaptotagmin-1 Utilizes Membrane Bending and SNARE Binding to Drive Fusion Pore Expansion 2008 ·Molecular Biology of the Cell ·Kara L. Lynch, Roy Gerona, (unknown), Sascha Martens, Harvey T. McMahon, Thomas F.J. Martin	99

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact